| Quantitative systems pharmacology: an exemplar model‐building workflow with applications in cardiovascular, metabolic, and oncology drug development G Helmlinger, V Sokolov, K Peskov, KM Hallow, Y Kosinsky, V Voronova, ... CPT: pharmacometrics & systems pharmacology 8 (6), 380-395, 2019 | 47 | 2019 |
| Quantitative mechanistic modeling in support of pharmacological therapeutics development in immuno-oncology K Peskov, I Azarov, L Chu, V Voronova, Y Kosinsky, G Helmlinger Frontiers in immunology 10, 450826, 2019 | 34 | 2019 |
| Next approximation of the random walk theory for Brownian coagulation MS Veshchunov, IB Azarov Journal of aerosol science 47, 70-77, 2012 | 24 | 2012 |
| Role of T cell-to-dendritic cell chemoattraction in T cell priming initiation in the lymph node: an agent-based modeling study I Azarov, K Peskov, G Helmlinger, Y Kosinsky Frontiers in immunology 10, 443009, 2019 | 19 | 2019 |
| Development of the new approach to the Brownian coagulation theory: transition regime IB Azarov, MS Veshchunov Journal of Engineering Thermophysics 19 (3), 128-137, 2010 | 19 | 2010 |
| Advancement of the kinetic approach to Brownian coagulation on the base of the Langevin theory PV Polovnikov, IB Azarov, MS Veshchunov Journal of Aerosol Science 96, 14-23, 2016 | 11 | 2016 |
| AZD8233 Antisense Oligonucleotide targeting PCSK9 does not prolong QT interval BC Dinko Rekić, Ivan Azarov, Jane Knöchel, Victor Sokolov, Catarina Nilsson ... British journal of clinical pharmacology, 2022 | 10 | 2022 |
| On the theory of point defect recombination in crystals IB Azarov, MS Veshchunov Journal of Experimental and Theoretical Physics 119, 473-478, 2014 | 6 | 2014 |
| Elaborating on anti CTLA-4 mechanisms of action using an agent-based modeling approach I Azarov, G Helmlinger, Y Kosinsky, K Peskov Frontiers in Applied Mathematics and Statistics, 106, 2022 | 2 | 2022 |
| Linking tumor microenvironment properties in murine syngeneic tumors with resistance to immune checkpoint inhibitors: Insights from a quantitative systems approach G Helmlinger, I Azarov, Y Kosinsky, V Voronova, L Chu, S Mosely, ... Cancer Research 79 (13_Supplement), 1082-1082, 2019 | 2 | 2019 |
| Condensation rate of light vapour molecules in the transition regime MS Veshchunov, IB Azarov Journal of Aerosol Science 86, 13-23, 2015 | 2 | 2015 |
| Comparison of different approaches to modeling early tumor size dynamics for accurate prediction of survival in non-small cell lung cancer (NSCLC) clinical trials Y Kosinsky, I Azarov, L Chu, G Helmlinger, K Peskov, S Aksenov JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS 45, S123-S123, 2018 | 1 | 2018 |
| Mechanistic insights and dose optimization for AZD3458, a novel selective PI3Kg immuno-modulator, using a quantitative systems approach PM Gutierrez, Y Kosinsky, K Peskov, I Azarov, L Chu, V Voronova, ... Cancer Research 79 (13_Supplement), 104-104, 2019 | | 2019 |
| Using Quantitative Systems Pharmacology modeling to predict response and resistance of immune checkpoint inhibitors (ICI) in murine syngeneic tumors I Azarov, Y Kosinsky, V Voronova, L Chu, SIS Sitnikova, S Dovedi, ... Mathematical modelling in biomedicine, 13, 2019 | | 2019 |
| Extension of mechanistic code SFPR to modelling UO {sub 2} fuel rods behaviour in fast reactors MS Veshchunov, AV Boldyrev, VD Ozrin, VE Shestak, VI Tarasov, ... | | 2011 |
| A new approach to the theory of Brownian coagulation MS Veshchunov, IB Azarov | | |
Kirill PeskovDirector, M&S DecisionsVerified email at msdecisions.ru
